Literature DB >> 4622479

An unusual plaque variant of rubella virus.

J J Gould, G D Laurence, M Butler.   

Abstract

In a comparative study of 24 different rubella virus strains, all but three formed small plaques in RK 13 cell cultures; of these one was the vaccine strain HPV-77, one was isolated from a congenitally infected infant, and the third was recovered from an adult who contracted severe rubella while handling this congenital strain. Whereas the plaque size of the vaccine strain was stable after further passage in cell culture, the plaque size of the other two rapidly diminished when the virus was passed in monkey kidney cells, and one of them was also reduced by passage in RK 13 cells. Cell culture passage of the typical small plaque strains did not result in altered plaque size.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4622479      PMCID: PMC2130025          DOI: 10.1017/s0022172400022087

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  3 in total

1.  Markers of rubella virus strains in RK13 cell culture.

Authors:  A Fogel; S A Plotkin
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103

2.  Attenuated rubella virus. I. Development and laboratory characterization.

Authors:  P D Parkman; H M Meyer; R L Kirschstein; H E Hopps
Journal:  N Engl J Med       Date:  1966-09-15       Impact factor: 91.245

3.  Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests.

Authors:  J M Best; J E Banatvala
Journal:  J Gen Virol       Date:  1970-12       Impact factor: 3.891

  3 in total
  2 in total

1.  Improvement of the specific infectivity of the rubella virus (RUB) infectious clone: determinants of cytopathogenicity induced by RUB map to the nonstructural proteins.

Authors:  K V Pugachev; E S Abernathy; T K Frey
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

2.  Sequence variation and biological activity of rubella virus isolates.

Authors:  P Londesborough; L Ho-Terry; G Terry
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.